AlphaMark Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $4K | Hold |
667
| – | – | ﹤0.01% | 540 |
|
2024
Q3 | $2K | Hold |
667
| – | – | ﹤0.01% | 637 |
|
2024
Q2 | $2K | Hold |
667
| – | – | ﹤0.01% | 686 |
|
2024
Q1 | $2K | Hold |
667
| – | – | ﹤0.01% | 673 |
|
2023
Q4 | $1K | Hold |
667
| – | – | ﹤0.01% | 704 |
|
2023
Q3 | $1K | Hold |
667
| – | – | ﹤0.01% | 716 |
|
2023
Q2 | $1K | Hold |
667
| – | – | ﹤0.01% | 606 |
|
2023
Q1 | $1K | Hold |
667
| – | – | ﹤0.01% | 601 |
|
2022
Q4 | $1K | Hold |
667
| – | – | ﹤0.01% | 575 |
|
2022
Q3 | $1K | Hold |
667
| – | – | ﹤0.01% | 672 |
|
2022
Q2 | $1K | Hold |
667
| – | – | ﹤0.01% | 615 |
|
2022
Q1 | $2K | Hold |
667
| – | – | ﹤0.01% | 561 |
|
2021
Q4 | $2K | Hold |
667
| – | – | ﹤0.01% | 533 |
|
2021
Q3 | $4K | Hold |
667
| – | – | ﹤0.01% | 495 |
|
2021
Q2 | $7K | Hold |
667
| – | – | ﹤0.01% | 435 |
|
2021
Q1 | $6K | Hold |
667
| – | – | ﹤0.01% | 431 |
|
2020
Q4 | $3K | Hold |
667
| – | – | ﹤0.01% | 460 |
|
2020
Q3 | $3K | Hold |
667
| – | – | ﹤0.01% | 477 |
|
2020
Q2 | $3K | Hold |
667
| – | – | ﹤0.01% | 475 |
|
2020
Q1 | $2K | Hold |
667
| – | – | ﹤0.01% | 483 |
|
2019
Q4 | $3K | Hold |
667
| – | – | ﹤0.01% | 441 |
|
2019
Q3 | $3K | Hold |
667
| – | – | ﹤0.01% | 445 |
|
2019
Q2 | $3K | Hold |
667
| – | – | ﹤0.01% | 459 |
|
2019
Q1 | $3K | Hold |
667
| – | – | ﹤0.01% | 448 |
|
2018
Q4 | $2K | Hold |
667
| – | – | ﹤0.01% | 446 |
|
2018
Q3 | $3K | Hold |
667
| – | – | ﹤0.01% | 463 |
|
2018
Q2 | $2K | Hold |
667
| – | – | ﹤0.01% | 490 |
|
2018
Q1 | $3K | Hold |
667
| – | – | ﹤0.01% | 463 |
|
2017
Q4 | $4K | Hold |
667
| – | – | ﹤0.01% | 444 |
|
2017
Q3 | $3K | Hold |
667
| – | – | ﹤0.01% | 460 |
|
2017
Q2 | $3K | Hold |
667
| – | – | ﹤0.01% | 471 |
|
2017
Q1 | $2K | Buy |
+667
| New | +$2K | ﹤0.01% | 468 |
|